# OnCo record breast-implant-associated-alcl (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/breast-implant-associated-alcl/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "breast-implant-associated-alcl" ;
  schema:name "Breast implant-associated anaplastic large cell lymphoma"@en ;
  schema:alternateName "BIA-ALCL"@en, "Breast implant-associated ALCL"@en, "Breast implant-associated anaplastic large-cell lymphoma"@en, "Implant-associated ALCL"@en, "Breast implant lymphoma"@en ;
  schema:description "A rare lymphoma that grows in the scar capsule the body forms around a breast implant, usually many years after the operation, and usually shows itself as sudden swelling of the breast from fluid around the implant. It is linked to textured implants, and when it is confined to the capsule it is usually cured by removing the implant and the capsule whole."@en ;
  schema:url <https://onco.cc/cancers/breast-implant-associated-alcl/> ;
  schema:dateModified "2026-09-29"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Anaplastic_large-cell_lymphoma> ;
  schema:citation <https://doi.org/10.1038/s41375-022-01620-2>, <https://doi.org/10.1182/blood.2022015851>, <https://doi.org/10.1001/jamaoncol.2017.4510>, <https://doi.org/10.1007/s00266-024-03956-9> ;
  onco:tag "heme", "lymphoma", "subtype-page" ;
  onco:related <https://onco.cc/cancers/alk-negative-anaplastic-large-cell-lymphoma/>, <https://onco.cc/cancers/alk-positive-anaplastic-large-cell-lymphoma/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/histopathology-ihc/> ;
  onco:targets <https://onco.cc/targets/cd30/> ;
  onco:terms <https://onco.cc/terms/bia-alcl/>, <https://onco.cc/terms/lymphoma-classification-2022/>, <https://onco.cc/terms/lymphoma-nodal-versus-extranodal/>, <https://onco.cc/terms/lymphoma-b-versus-t-cell/> ;
  onco:standardOfCare <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/targets/cd30/>, <https://onco.cc/terms/bia-alcl/>, <https://onco.cc/terms/bia-alcl/>, <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/cancers/alk-negative-anaplastic-large-cell-lymphoma/>, <https://onco.cc/drugs/brentuximab-vedotin/>, <https://onco.cc/terms/lymphoma-tx-radiotherapy/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/> .